Ratib Ali

2 months ago | ipwatchdog.com | Ratib Ali |Steve Brachmann

IPWatchdog LIVE Moves to March in 2025: Click for details “By requiring human contribution beyond just operating an AI tool, the USCO extends copyright protections to endeavors that contribute to the advancement of human creativity.”Copyrightability of AI-generated and AI-assisted work has been a hot topic for a while. The United States Copyright Office (USCO) clarified its position on AI contributions in its 2023 guidelines.

Dec 4, 2024 | ipwatchdog.com | Brad Close |Ratib Ali |Eileen McDermott |Pinar Gencer

Support IPWatchdog with an individual sponsorship: Click here “Far from being a public harm, litigation finance is a net public good according to the panel, because it supports a secondary market for patent rights.”IPWatchdog has previously reported on aspects of litigation financing, including a recent article on inventor groups being wary of asymmetrical demands for transparency in revealing funding sources.

Sep 23, 2024 | law360.com | Jonathan F. Putnam |Ngoc Minh Ngo |Ratib Ali

By Jonathan Putnam, Ngoc Ngo and Ratib Ali (September 23, 2024, 5:28 PM EDT) -- Recently, the Federal Trade Commission has pushed to compel the delisting of certain patents held by branded drug manufacturers from the U.S. Food and Drug Administration's "Orange Book" database, on the grounds that they do not claim the underlying drug.... Law360 is on it, so you are, too.